Cobra Biologics Appoints John Birch Non-Executive Director

Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals, announces the appointment of a new non-executive director to Cobra Biologics' board to provide further experience in the CMO sector as Cobra continues to expand with increased capacity and a 40% increase in headcount in the last 12 months.

The appointment of John Birch, former Chief Scientific Officer for Lonza Biopharmaceuticals, as a non-executive director will provide Cobra's board with experience in the CMO sector.